In view of the great demand for human beta-cells for physiological and medical studies, we generated cell lines derived from human insulinomas which secrete insulin, C-peptide and express neuroendocrine and islet markers. In this study, we set out to characterize their proteomes, comparing them to those of primary beta-cells using DIGE followed by MS. The results were validated by Western blotting. An average of 1800 spots was detected with less than 1% exhibiting differential abundance. Proteins more abundant in human islets, such as Caldesmon, are involved in the regulation of cell contractility, adhesion dependent signaling, and cytoskeletal organization. In contrast, almost all proteins more abundant in insulinoma cells, such as MAGE2, were first described here and could be related to cell survival and resistance to chemotherapy. Our proteomic data provides, for the first time, a molecular snapshot of the orchestrated changes in expression of proteins involved in key processes which could be correlated with the altered phenotype of human beta-cells. Collectively our observations prompt research towards the establishment of bioengineered human beta-cells providing a new and needed source of cultured human betacells for beta-cell research, along with the development of new therapeutic strategies for detection, characterization and treatment of insulinomas.
Introduction
The vertiginous increase in the number of diabetic patients in the world has rendered Diabetes mellitus (DM) to be considered as a severe Public Health problem. Type 1 DM (DM1) is a pathology characterized by auto-immune destruction of beta-cells, which causes an absolute deficiency in insulin production, leading to several neurological, renal, ocular and cardiovascular complications. This auto-immune destruction occurs when the beta-cells are infiltrated by macrophages and lymphocytes that secret a variety of cytokines to which the beta-cells are extremely sensitive, resulting in beta-cell apoptosis (Nielsen et al., 1999 (Nielsen et al., , 2004 .
Because of the absolute deficiency in insulin production, DM1 patients require administration of daily doses of exogenous insulin to maintain normal glucose levels in their bloodstream. In order to adequately correct the blood glucose levels and minimize the complications which appear as a result of the frequent metabolic imbalance, insulin therapy requires severe adherence of the patient to the treatment (DC and CTR 1993) . Hypoglycemic episodes 0303-7207/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mce.2013.07.004
Abbreviations: CALD1, Caldesmon; MAGE-A2, Melanoma Associated Antigen-A2; NR6A1, Nuclear Receptor Subfamily 6 Group A Member 1; OTUD7A, OTU domain-containing protein 7A.
q Significance: The results obtained in the present study point at the potential value of the proteins uncovered here, since almost all proteins presenting increased levels in insulinoma cells, such as MAGE2, were first described in this study and could be related to cell survival as well as to resistance to chemotherapeutic agents. It is worth mentioning that the data obtained may also contribute to the still scarce knowledge on the molecular biology of human insulinomas. Finally, our study warrants further validation of some of these proteins in larger cohort samples as well as consideration for the development of insulinoma biomarkers and detection.
and weight gain are also consequences of the continuous exogenous insulin application (Dong and Woo, 2001; Kido et al., 2000) . Therefore, it is crucial to understand the mechanisms involved in beta-cells proliferation and differentiation in order to develop protocols to augment the available number of these cells for transplantation and also, to allow induction of endogenous beta-cells regeneration in recently-diagnosed DM1 patients and in insulindependent type 2 DM (DM2) patients, where a significant reduction in beta-cell mass is also observed.
One of the main obstacles in human beta-cell research has been the lack of a proper human pancreatic beta-cell line not only because of difficulties in obtaining them, but also in culturing these cells for long periods of time (Adcock et al., 1975; Gragnoli, 2008) . Therefore, rodent insulinoma cell lines have been widely used to study both physiological and pathophysiological mechanisms involved in glucose metabolism and to establish in vitro models for the beta-cell damage occurring in type 1 diabetes (Frodin et al., 1995; Gylfe and Hellman, 1986; Hill et al., 1987; Meglasson et al., 1986; Trautmann and Wollheim, 1987; Verspohl et al., 1995) . Nevertheless, studies comparing sequences lying upstream of, or flanking the transcription start site of the insulin gene among different species, led to the conclusion that the rodent promoters are markedly different from the human one (Hay and Docherty, 2006) . Moreover, nitric oxide formation, shown to be an important mediator of cytokine-induced beta-cell death in rodents, does not affect cytokine-mediated beta-cell death in human islets (Eizirik et al., 1994 (Eizirik et al., , 1996 . The signal transduction pathways induced by the pro-inflammatory cytokines IL-1b and TNF-a differ (Ortis et al., 2010 (Ortis et al., , 2008 , and although both are present during islet inflammation, they seem to appear at different time windows (Eizirik et al., 2009) . These important differences in the cytokine-induced response in rodent and human beta-cells urge caution when we directly translate the research results obtained in rodents to the human disease etiology and therapy.
Insulinomas are the most common pancreatic endocrine neoplasms, representing approximately 17% of all neuroendocrine tumors of the digestive tract (Buchanan et al., 1986) , constituting rare tumors, with an incidence of four patients per million inhabitants a year (Boden, 1989; Oberg and Eriksson, 2005; Tucker et al., 2006) . Most insulinomas originate in individuals with a mean age of 50 years, being usually small (less than 2 cm), solitary and almost always benign (more than 90% of cases) (Boden, 1989; Oberg and Eriksson, 2005; Proye, 1987) . Malignant insulinomas are often associated with local invasion of adjacent tissues or with liver and lymph nodes metastasis (Oberg and Eriksson, 2005; Broder and Carter, 1973) . The main clinical manifestation of insulinomas is hypoglycemia, due to uncontrolled insulin secretion by the tumor (Oberg and Eriksson, 2005) .
For insulinoma treatment, the usual method of choice is tumor ablation (Oberg and Eriksson, 2005; Menegaux et al., 1993) ; however, a major issue faced by surgeons is the exact localization of the tumor in the pre-and, mainly, intraoperatory, since no imaging technique is sufficiently accurate (Tucker et al., 2006; Machado et al., 1998) . Due to the fact that these are rare tumors, knowledge about genetic changes associated with initiation and progression of these tumors is very limited.
Only a few human beta-cell lines have been described, with long-term passage resulting in loss of insulin secretion (Gartner et al., 2006; MacFarlane et al., 1999) . Therefore, we have established and characterized human insulin-releasing cell lines, which may not perfectly mimic the primary beta-cell physiology, but still represent valuable tools for the study of the molecular events underlying beta-cell function and dysfunction (Labriola et al., 2009) .
In order to further characterize the differences between normal human beta-cells-enriched islets cultures and our developed betacell lines, we set out to study the molecular mechanisms involved in beta-cell proliferation and secretory function, by comparing the protein expression profiles of these primary cultures of human pancreatic islets and the human cell lines derived from isolated insulinomas through two-dimensional gel electrophoresis (2D-DIGE) and mass spectrometry. The results obtained in this study are relevant to increase knowledge on the molecular biology of insulinomas, aiming at selection and/or validation of new therapeutic targets and diagnostic biomarkers, since these differentially expressed proteins could be related to the malignancy displayed by these cells.
Materials and methods

Human pancreatic islet isolation and culturing
Human pancreases from adult brain-dead donors (mean age 42 ± 3 years, n = 14) were removed in accordance with Brazilian regulations and the local institutional ethics committee. For characterization of human islet donors, see Supplementary Table 1 . Pancreatic islets were isolated after ductal distension of the pancreas and digestion of the tissue with Liberase HI (Roche Diagnostics, Indianapolis, IN, USA) or Collagenase (Serva Electrophoresis GmbH, Heidelberg, Germany), utilizing the Ricordi automated method (Ricordi et al., 1988) , with modifications, as previously described (Adams and Cory, 1998; Shapiro and Liu, 1995) .
Islets were maintained in CMRL 1066 medium (5.6 mM glucose) (Mediatech-Cellgro, Miami, FL, USA) supplemented with 10% fetal calf serum (FCS) (Cultilab, Campinas, SP, Brazil) and 100 units/mL streptomycin/ampicilin.
In all cases, the culture medium was changed every 2-3 days. At confluence or when cell clusters became overcrowded, the cells were detached with 0.025% trypsin, washed, and resuspended in fresh medium. All cell culture experiments were performed at 37°C in a 5% CO 2 humidified atmosphere. These cultures display at least 85% of beta-cells, according to our previous results (Labriola et al., 2007; Maria-Engler et al., 2004) .
Primary cultures of human insulinoma cells
Ex vivo primary culture of insulinomas (APM and CPR cells) and nesidioblastosis (VGA cells) were obtained from independent donors after surgical resection and tissue processing. Tumor tissue samples were removed upon informed consent from patients enrolled in a protocol of the Bile Ducts and Pancreas Service duly approved by the Institutional Board of the Hospital das Clínicas, FMUSP and then processed. After collagenase digestion of these samples, cells were plated in culture flasks in CMRL 1066 medium (Mediatech-Cellgro) supplemented with ITS (10 mg/L insulin, 5.5 mg/L transferring, 0.0067 mg/L sodium selenite, 2 mg/L ethanolamine, GIBCO Corporation, Carlsbald, CA, USA), 100 units/mL streptomycin/ampicilin, 10% FCS and glucose (final concentration 11 mM) and allowed to attach for 24-48 h. In all cases, the culture medium was replaced every 2-3 days. At confluence or when the cell clusters became overcrowded, the cells were detached with 0.025% trypsin, washed, and resuspended in fresh medium. All cultures were maintained at 37°C in a humidified atmosphere (Labriola et al., 2009) . Data pertinent to the human insulinoma-derived cell line preparations used in this work, including insulin response data, are listed in Table 1 .
Samples preparation
Primary cultures of human islets (passages 1-3), highly enriched in beta-cells, and APM cells (Labriola et al., 2009 ) were washed with ice-cold PBS and then lysed by scraping at 4°C in a lysis buffer (10 mM Tris pH: 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1 mM DTT, 1% NP-40, 0.1% SDS, protease (GE Healthcare, Buckinghamshire, UK) and phosphatase (Sigma Aldrich St. Louis, MO, USA) inhibitors cocktails, following the manufacturer's instructions). The homogenates were centrifuged at 4°C for 30 min at 12,000g and the supernatant fractions were then collected and stored at À70°C. The protein content was quantified using the Bradford colorimetric assay (Bio-Rad, Richmond, CA, USA). Aliquots containing 200 lg of proteins were treated with the 2D Clean-up kit (GE Healthcare), following the manufacturer's instructions. The protein pellets were resuspended in rehydration solution for isoelectric focusing (8 M urea; 2% CHAPS; 13 mM DTT) and protein concentration was determined using Bradford as previously described.
Sample labeling and comparison using fluorescent dyes
Prior to the labeling step, the samples' pH was adjusted to 8.5 using 1 mM NaOH. Aliquots (50 lg) of protein from each sample were labeled with the DIGE cyanides, Cy3 and Cy5, following the manufacturer's instructions (GE Healthcare). For the internal standard, equal amounts of protein from each extract were labeled with Cy2. The labeling reaction was carried out at 4°C for 30 min in the dark, and the dyes' excess was eliminated by the addition of 1 mM lysine. In order to eliminate any preferential or non-specific labeling, the reverse labeling was also performed.
After labeling, the samples to be compared were mixed and dissolved in sample buffer (De-streak solution (GE Healthcare), 0.5% IPG buffer).
Four independent experiments were performed using total protein extracts corresponding to different human insulinoma passages, compared to equal amounts of protein from four different primary cultures of human pancreatic islets. The internal standard loaded in every analytical gel contained a mixture of equal amounts of protein from all samples.
Generation of protein profiles using analytical 2D gels
Individual 24 cm IPG strips, pH 3-10 L, were re-hydrated for 16 h at room temperature in 450 lL of the sample mixture, which was solubilized in a re-hydration buffer (De-streak solution (GE Healthcare), IPG buffer).
The rehydrated strips were electrofocused using an Ettan IPGphor 3 system (GE Healthcare). Focused strips were stored at À70°C, or directly used for the second dimension. Equilibration of the IPG strips after isoelectric focusing was carried out in two steps: reduction (10% Tris-Cl pH 8.8; 6 M Urea; 30% glicerol, 0.07 M SDS; 1% w/v DTT), followed by alkylation (10% Tris-Cl pH 8.8; 6 M Urea; 30% glycerol, 0.07 M SDS; 4% iodoacetamine and bromophenol blue). Each step was performed for 10 min on a standard benchtop shaker. In the second dimension, electrofocused proteins were fractionated in a 12.5% polyacrylamide SDS gel (25 Â 20 Â 0.1 cm; Ettan Dalt Six -GE Healthcare). Each gel was loaded with one strip. The gels were run at 20°C with a constant power of 5 W/gel for 45 min., followed by 17 W/gel until the end of the run.
After the second dimension, the gels were washed and scanned using the Typhoon 9400 gel Imager (GE Healthcare) and lasers at three different excitation wavelengths (532 nm for Cy3; 633 nm for Cy5 and 488 nm for Cy2), with specific filters for the wave lengths of each fluorophore (580 nm-BP: 30 nm for Cy3; 670 nm-BP: 30 for Cy5 and 520 nm-BP: 40 nm for Cy2). The gels were scanned with a resolution of 100 lm and the phototube multiplier value (PTM) was fixed at a value which guaranteed the highest intensity of the pixels. For image analysis was used the DeCyderTM Software Version 6.5 (GE Healthcare), according to the manufacturer's instructions.
Determination of Molecular Weight (MW) and pI
Molecular weight values for the individual proteins on the gels were interpolated from SDS-PAGE Standards (Invitrogen, Carlsbald, CA, USA), which consisted of multiple proteins with molecular weight values ranging from 15 to 170 kDa. The pI was directly calculated by interpolation from the pI in the linear gradient of the strips (pH: 3-10).
Generation and staining of preparative gels
A pool of all samples (500-2000 lg of total proteins) was loaded onto 24 cm strips, pH 3-10 L. The first and the second dimension electrophoresis were carried out under the same conditions applied to the analytical gels. The Deep Purple dye was used for gel staining according to manufacturer's instructions (GE Healthcare). 
a Stimulation index = insulin secretion (20 mM glucose): insulin release (2.8 mM glucose). b Neuroendocrine and islet cells markers. c Ductal and exocrine cells markers.
Spot processing for mass spectrometry
The spots of interest were excised from the gels using a robot (GE Healthcare), cut into smaller pieces and transferred to low protein binding polypropylene tubes (Eppendorf, Hamburg, Germany). The gel slices were washed 3 times for 15 min each with Acetonitrile (ACN) 50%, 25 mM ammonium bicarbonate (NH 4 HCO 3 ) and dehydrated with ACN 100% for 5 min followed by vacuum centrifugation. Gel slices were rehydrated and subjected to disulphide bond reduction with 10 mM DTT, 100 mM NH 4 HCO 3 for 1 h at 56°C. The free cysteins were alkylated using 55 mM Iodoacetamide, 100 mM NH 4 HCO 3 for 45 min in the dark and then washed twice for 15 min each with 100 mM NH 4 HCO 3 . Gel slices were dehydrated with ACN 100% for 5 min followed by vacuum centrifugation and rehydration in digestion buffer containing Trypsin Gold mass spectrometry grade (Promega, Madison, WI, USA), incubated for 1 h at room temperature and then overnight at 37°C.
The supernatant was transferred to a low protein binding tube and tryptic peptides were extracted from the gel slices using ACN 50%, Trifluoroacetic acid (TFA) 5% for 30 min.
The peptides were desalted using Zip Tip C18 columns (Millipore, Billerica, MA, USA) according to the manufacturer's instructions.
Mass spectrometry peptide analysis and identification
The samples leading to the identification of Caldesmon, 14-3-3, NR6A1, Dermcidin and OTUD7A were analyzed by a nanoflow HPLC (EasynLC; Proxeon Biosystem, Odense, Denmark) coupled on-line via a nanoelectrospray ion source (Proxeon Biosystems) to a LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Peptide mixtures were loaded onto a C18-reversed phase column (15 cm long, 100-lm inner diameter, packed in-house with ReproSil-Pur C18-AQ 3-lm resin) in buffer A (0.1% formic acid) and eluted with a linear gradient from 2% to 40% buffer B (90% ACN and 0.1% formic acid solution) at a flow rate of 250 nL/min over 20 min. After each sample, the column was washed with 90% buffer B and re-equilibrated with buffer A.
Mass spectra were acquired in the positive ion mode applying a data-dependent automatic switch between survey MS scan and tandem mass spectra (MS/MS) acquisition. Samples were analyzed by acquiring one Orbitrap survey MS scan in the mass range of m/z 300-2000 in the orbitrap, followed by MS/MS of the five most intense ions in the LTQ. The target value in the LTQ-Orbitrap was 1,000,000 ions for survey scan at a resolution of 60,000 at m/z 400 using lock masses for recalibration to improve the mass accuracy of precursor ions. Fragmentation in the LTQ was performed by collision-induced dissociation with a target value of 20,000 ions. Ion selection threshold was set to 5000 counts. Selected sequenced ions were dynamically excluded for 30 s.
Peak lists (mgf files) were extracted from the raw data using the Proteome Discoverer 1.2 (Thermo Scientific) Program. Database searches were performed using the MASCOT (Version 2.1.0 and 2.2.04, Matrix Science, Boston, MA, USA) search program. The search parameters were set to: MS accuracy 10 ppm, MS/MS accuracy 0.5 Da, Trypsin digestion with two missed cleavage allowed, fixed carbamidomethyl modification of cysteine and variable modification of oxidized methionine. The tandem mass spectra from the MS/MS experiments were searched against the IPI human, non-redundant database, downloaded April 2010. Searches were carried out using a requirement of two unique peptides for protein identification, with an individual Mascot ion score cut off set to 95% significance. Mascot searches of the data set against a decoy database resulted in a false discovery rate of less than 1%, with no proteins being identified with the applied significance cut off limits. All identifications were manually validated and protein molecular weight and pI were considered for further validation.
The samples leading to the identification of GAPDH, MAGE2, NEUA and PKN1 had their peptides eluted onto an analytical C18 column (75 lm i.d. Â 100 mm) (Waters, Milford, MA, USA) using a 45 min gradient at a flow rate of 400 nL/min where solvent A was 0.5% formic acid and solvent B was 0.5% formic acid in acetonitrile. The gradient was 0-80% acetonitrile in 0.5% formic acid over 45 min. A LTQ XL mass spectrometer (Thermo, San Jose, CA, USA) was used to acquire spectra. Spray voltage was set at 2.5 kV and the instrument was operated in data dependent mode, in which one full MS scan was acquired in the m/z range of 300-1600 followed by MS/MS acquisition using collision induced dissociation of the ten most intense ions from the MS scan. A dynamic peak exclusion was applied to avoid the same m/z of being selected for the next 120 s.
Peak lists (mgf files) were extracted from the raw data using the Trans-Proteomic Pipeline platform (Keller et al., 2005) and the corresponding mgf files were searched using the MASCOT search engine (Version 2.1.0 and 2.2.04, Matrix Science) against the IPI human, non-redundant database. Iodoacetamide derivative of cysteine and oxidation of methionine were specified in MASCOT as fixed and variable modifications, respectively. The searches were carried out with a requirement of two unique peptides for protein identification, with an individual Mascot ion score cut off set for 95% significance. Mascot searches of the data set against a decoy database resulted in a false discovery rate of less than 1%, with no proteins being identified with the applied significance cut off limits. All identifications were manually validated and protein molecular weight and pI were considered for further validation.
Western blots
Total extracts were prepared from primary cultures of pancreatic islets and insulinoma cells. For analysis of GAPDH and MAGE-A, equal amounts (100 lg) of proteins from each extract were solubilized in sample buffer (60 mmol/l Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 0.01% bromophenol blue) and subjected to SDS-PAGE (12%). As for the quantification of expression levels of Caldesmon, individual 11 cm IPG strips, pH 4-7 nL, were rehydrated in 250 lL of sample, which was solubilized in rehydration buffer (De-streak solution (GE Healthcare), IPG buffer) at 20°C for 15 h. The rehydrated strips were focused on an Ettan IPGphor 3 system (GE Healthcare). Focused strips were stored at À70°C, or directly used for the second dimension. Equilibration of the IPG strips after isoelectric focusing was performed in two steps: reduction (10% Tris-Cl pH 8.8; 6 M Urea; 30% glycerol, 0.07 M SDS; 1% w/v DTT), followed by alkylation (10% Tris-Cl pH 8.8; 6 M Urea; 30% glycerol, 0.07 M SDS; 4% Iodoacetamide and bromofenol blue). Each step was performed for 10 min on a standard benchtop rshaker. For the second dimension, the electrofocused proteins were fractionated using 8% polyacrylamide SDS gel electrophoresis (15 Â 12.5 cm; MidiVertigel2 -Apelex, Lisses, France). Each gel was loaded with one strip.
Proteins were then transferred to nitrocellulose membranes, which were previously blocked and then incubated with mouse monoclonal anti-GAPDH antibody (sc-137179; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse monoclonal anti-L-Caldesmon antibody (sc-25339; Santa Cruz Biotechnology) or mouse monoclonal anti-MAGE-A antibody (sc-71539; Santa Cruz Biotechnology). The membranes were then incubated with horseradish peroxidase-conjugated secondary antibody (Vector Laboratories, Burlingame, CA, USA). Enhanced chemiluminescence was achieved according to the manufacturer's instructions (Amersham Biosciences, Little Chalfont, UK). As a loading control, the membranes were stripped and re-probed with mouse monoclonal anti-tubulin antibody (SC-5274; Santa Cruz Biotechnology). Quantitative densitometry was carried out using a scanner (Scanjet 3500; Hewlett Packard, São Paulo, Brazil) and ImageQuant 5.2 software (Molecular Dynamics, Amersham Biosciences).
Statistical analysis
The statistical differences between the mean ratios of spots from both groups (normal islets versus insulinomas) were tested using the non-paired Student's t-Test, automatically generated by the BVA module of DeCyder V6.5, considering as statistically relevant p < 0.05. This software generates a ratio of sample spot volume with pooled standard spot volume and normalizes these ratios so that the modal peak volume ratio within each gel is zero. An algorithm, which normalizes the volume ratios of each spot across the replicate gels against the smallest volume ratio of the same spot, was applied in order to generate the standardized spot abundance. The standardized abundance values were then subjected to statistical analysis.
On Western blots the volume density of the chemiluminescent bands was calculated as integrated optical density Â mm 2 after background correction. The statistical differences between group means were tested by either unpaired two-tailed Student's t-Test or One-way ANOVA followed by Tukey's Multiple Comparison Test. A ''p'' value < 0.05 was considered statistically significant.
Results
Protein expression profiles of human insulinoma cells as compared to normal beta-cells-enriched islet cultures
The 2D map shown in Fig. 1 is representative of the pattern obtained for beta-cells-enriched primary cultures of human islets and human insulinoma cultures. An average of 1800 spots was detected in the analytical gels.
In order to address sample similarity, the four pairs of gels were matched using the DeCyderTM Software Version 6.5 (GE Healthcare), as described in the material and methods. It is important to note that the high resolution and highly reproducible 2D pattern obtained has led to a high proportion of paired spots. Indeed, approximately 60% of the spots were present in all gels.
By applying the non-paired Student's t-Test generated by the BVA module of DeCyder V6.5 and considering as statistically relevant p < 0.05, we were able to identify 11 spots of differential abundance between insulinoma and beta-cells-enriched islet cultures, eight of which displayed increased abundance by at least two standard deviation (SD) folds in insulinoma samples and three displayed decreased abundance when compared with the islet samples. It is noteworthy that not only the majority of the spots appeared in all of our gels, showing that these experiments are quite reproducible, but also that only 0.6% of the proteins were differentially expressed with statistical significance, which strongly suggests that these insulinoma cells could lead to very close models of human beta-cells. Fig. 1 shows a representative 2D gel in which all excised spots, i.e. nine differentially abundant spots (black arrows) and eight non-differentially abundant ones are indicated. Fig. 2 exemplifies the numerical data used for protein level quantification, displayed here as 3D graphics, of some spots, namely: 1799, 1780, 1724 and 1241.
It should be taken into account that the large dispersion among values when comparing cells from different donors and the similarities found between the APM insulinoma cell line and the beta-cell-enriched islet cultures might have contributed to a reduced number of spots of differential abundance.
Proteins identified by mass spectrometry
In order to tackle protein identification, 17 spots, nine of which are differentially expressed, were excised from the preparative gels and nine proteins were positively identified by mass spectrometry representing a 53% success rate. It is worth mentioning that many of the non-identified proteins are of very low abundance, being present only in gels stained with fluorophores, and not with Coomassie. In addition, some are of very low molecular weight, which may have strongly contributed to this low identification success rate. Table 2 and Supplementary Table 2 show the identified proteins, together with information regarding accession number, insulinoma/islets abundance ratio, p value, theoretical and experimental MW and pI, score and sequence coverage. The group of non-differentially abundant spots was selected to ensure pI and molecular weight range. In the majority of the spots in which the theoretical MW or pI of the protein did not match the experimental data, the deviation could be accounted for by post-translational modifications, such as phosphorylation and/or glycosylation of these proteins, according to the literature. The remaining spots presented no reliable identification.
Caldesmon is more abundant in the beta-cells-enriched islet cultures when compared to the insulinoma cells. It is a calmodulinand actin-binding protein (Sobue and Sellers, 1991) whose roles in the regulation of cell contractility, adhesion dependent signaling, and cytoskeletal organization are well documented (Greenberg et al., 2008; Hai and Gu, 2006) , thus influencing granule movement, hormone secretion and reorganization of microfilaments.
A recent study has indicated that three major calmodulin-binding proteins are, in fact, located on the surface of the islet secretory granules and that they probably constitute most of the binding sites observed with whole secretion granules (Watkins and White, 1985) . Additionally, treating pancreatic beta-cells with a pharmacological inhibitor of calmodulin inhibits glucose-stimulated insulin release (Henquin, 1981; Sugden et al., 1979) . Nuclear Receptor Subfamily 6 Group A Member 1 (NR6A1) was the second protein identified to be more abundant in the islet cultures. It has been mainly described as being expressed in germ cells, and may be related to their development and maturation (Agoulnik et al., 1998; Chen et al., 1994; Katz et al., 1997) . Nevertheless, more recent findings have shown that NR6A1 is expressed in islets, as well as in other tissues such as brain, pituitary and parathyroid, although not as much as in testis, ovary, oviduct and lung (Lan et al., 2009 ), but little is known about its function in these tissues. The Melanoma Associated Antigen 2 (MAGE2, also known as MAGE-A2) was described here for the first time in human insulinomas, presenting increased protein levels in both APM and CPR human insulinoma cells. The MAGE-A gene family is located on chromosome X, region q28, being comprised of 12 members (MAGE-A1-12) De Plaen et al., 1994. They encode tumor-associated antigens which are recognized by cytolytic T lymphocytes (De Plaen et al., 1994; van der Bruggen et al., 1991) . Their expression is restricted to tumor cells of distinct origins, including melanoma, bladder, and stomach carcinoma (De Smet et al., 1995 Inoue et al., 1995; Liang et al., 2002) , rendering MAGE-A members as attractive targets for cancer detection and immunotherapy (De Plaen et al., 1994; van der Bruggen et al., 1991) . The 14-3-3 protein (f isoform) was also found to be more abundant in the APM cell line. The 14-3-3 proteins constitute a family of phosphoserine/phosphothreonine-binding molecules that has seven defined protein species, namely: b, e, c, g, r, s, and f. Initially, they were described as enzyme cofactors that affect the activity of a wide range of proteins involved in key signal transduction pathways including that of protein kinase C, function from which it received one of the many names it has been known for, protein kinase C inhibitor-1 (Aitken, 2006) . Therefore, dysregulation of 14-3-3 has been associated with pathological consequences.
Dermcidin was also identified as being more abundant in the APM cell line. It was first identified in sweat glands (Schittek et al., 2001 ), contributing to the first line of skin defense by building a constant barrier that overlies the epithelium (Schittek et al., 2008; Wiesner and Vilcinskas, 2010) , but later on it was also found in neuronal cells and peripheral blood leukocytes (Schittek, 2012) . More recently, several studies showed that dermcidin is also expressed in some cancer cells or cancer cell lines, including adenocarcinomas, invasive breast carcinomas, hepatocellular carcinoma, gastroesophageal tumors, pancreatic adenocarcinoma cell lines and in myelogenous leukemic cell line. Previous results showed that the expression of dermcidin in breast cancer cells promotes cell growth and survival and reduces serum dependency (Porter Fig. 2 . Quantification of Spots abundance in APM insulinoma cells and pancreatic islets protein extracts. 3D representations of spots presenting differential or non-differential abundance. Data are presented as mean relative expression values and t-Test p-value of all analyzed analytical gels (n = 4). Positive Ins/Isl ratio values represent an increased abundance in APM cells when compared to human islets, whereas negative values represent an increased abundance in the human islets. a Proteins identified by LTQ-Orbitrap XL (EasynLC; Proxeon Biosystem, Odense, Denmark). b Proteins identified by LTQ XL mass spectrometer (Thermo, San Jose, CA, USA). c The average ratio value was calculated by the BVA module of the Decyder™ Software (GE Healthcare), and indicates the standardized volume ratio between the two groups or populations. Values are displayed in the range of À1 to À1 for decreases in expression and +1 to +1 for increases in expression. Positive Ins/Isl ratio values represent an increased abundance in APM cells when compared to human islets, whereas negative values represent an increased abundance in the human islets. Eventhough the average ratio parameter is displayed in this manner, the statistical analyses are based on the log of the true ratio measurement. et al., 2003) . Moreover, several other studies demonstrated that dermcidin expression results in enhanced proliferation, survival and migration of cancer cells (Dash-Wagh et al., 2011; Lee Motoyama et al., 2007; Shen et al., 2011) .
Confirmation of protein expression profiles by Western blotting
In order to validate the data obtained from 2D gel electrophoresis and mass spectrometry, we confirmed the expression profiles and the identity of three different proteins by Western blotting. We have chosen Caldesmon and MAGE2 as proteins belonging to the differentially abundant spots group, which are downregulated and upregulated in the human insulinoma cultures, respectively, and GAPDH from the non-differentially expressed group.
MAGE-A was detected in the beta-cells-enriched primary cultures of human islets; however, in the APM human insulinoma cultures a significant (fivefold) increase in the level of this protein was observed (islets 0.27 ± 0.03; APM 1.3 ± 0.1; p < 0.05) (Fig. 3C) . Furthermore, since this was the first time that this protein was found in insulinoma cells, we set out to investigate MAGE-A expression in the other two human insulinomas cell lines also established by our group (Labriola et al., 2009) . Interestingly, we found that the VGA cell line, derived from a human nesidioblastosis, did not present any difference in MAGE-A protein levels when compared to the normal islet cultures (0.058 ± 0.004; p > 0.05). On the other hand, the CPR cell line, which like the APM cells, was also derived from an isolated human insulinoma, presented an increase (23 fold) in MAGE-A protein levels (6.04 ± 0.05; p < 0.05) (Fig. 3C) .
In our previous islet proteomic studies, Caldesmon was detected in two spots belonging to a horizontal strain of protein spots, and also presented more than two protein species in 1D gels (Labriola et al., 2007) . Since not all protein species were differentially expressed, we decided to probe 2D gels for Western Blot using an anti-Caldesmon antibody. In fact, during validation of our results by Western blotting, we have come across two spots for Caldesmon, which presented the same molecular weight but distinct pI values. This kind of shift in pI found in 2D gels could be explained by different stages of phosphorylation of the analyzed protein. The acidic spot showing a 30 fold decreased level in the human insulinoma cultures when compared to the beta-cells-enriched primary cultures of human islets (islets 17 ± 4; APM 0.6 ± 0.1; p < 0.05) and the basic spot did not show any difference in protein level (islets 31 ± 11; APM 2.5 ± 0.5; p > 0.05). Moreover, we observed a decrease (16 fold) total Caldesmon expression in the APM cell line (Fig. 3B) .
The presence of GAPDH was detected in human islet cultures without any change of the protein level when compared with the human insulinoma culture (Fig. 3A) , further validating the results obtained by the 2D-DIGE approach.
Discussion
In the present study, we set out to study the molecular mechanisms involved in beta-cell proliferation and secretory function, by comparing the protein expression profiles of beta-cells-enriched human pancreatic islet cultures and human insulinomas through two-dimensional electrophoresis (2D-DIGE) and mass spectrometry, in order to further characterize the proteomic differences between normal human islets cultures and the insulinoma cell lines previously established by our group (Labriola et al., 2009) . It is important to emphasize that we were able to identify new proteins that had never been described neither in human insulinomas nor in human islets and which are all related to the observed cell phenotype. Moreover, two of the validated proteins present opposite expression patterns and should be further investigated as molecular targets in order to better characterize the cellular biology of these poorly studied tumours.
Caldesmon is more abundant in the beta-cells-enriched islet cultures when compared to the insulinoma cells, and it appeared as two spots in the Western blot from 2D gels. It is known that an increase in both cellular calcium concentration and Caldesmon phosphorylation cause dissociation of Caldesmon from actin, resulting in weakening most of Caldesmon's properties (Huber, 1997) . This differential state of phosphorylation, as well as the decrease in total Caldesmon abundance in insulinoma cells when compared to beta-cells-enriched human pancreatic islet cultures, could be related to the lack of control in insulin secretion displayed by these cells.
Additionally, Caldesmon phosphorylation has also been shown to be an essential step in actin cytoskeletal remodeling during mitosis (Yamashiro et al., 1991 (Yamashiro et al., , 1990 , suggesting that Caldesmon phosphorylation is related to proliferation. In our results we observed a diminished state of phosphorylation in the APM cell line when compared to the human pancreatic islet cultures; however, we have already shown that these insulinoma cells present a doubling time of approximately 40 h, proliferating significantly more than the beta-cells-enriched human islets in culture (Labriola et al., 2009) .
Moreover, we have observed a very significant decrease in total Caldesmon protein levels in the APM cell line. Caldesmon has already been shown to negatively regulate the formation of podosomes and rosettes (Eves et al., 2006; Gu et al., 2007; Morita et al., 2007) . Interestingly, its expression has already been demonstrated to be downregulated in several transformed and cancer cells (Novy et al., 1991; Owada et al., 1984; Ross et al., 2000; Tanaka et al., 1993) and to be inversely correlated with the metastatic frequency in malignant melanoma (Koganehira et al., 2003) . Furthermore, Caldesmon was shown to be implicated in the suppression of cancer cell invasion . More recently, a mechanism through which p53 exercises potent anti-invasive functions by suppressing podosome/rosette formation and cell invasion via the upregulation of Caldesmon expression has been described (Mukhopadhyay et al., 2009 ).
NR6A1 was found as more abundant in the islet cultures. It binds to the consensus sequence TCAAGGTCA and direct repeats with 0 nucleotide spacing (DRO). At present, no ligand is known for NR6A1, and thus, it is currently classified as an orphan receptor (Chen et al., 1994) .
In normal adult tissues, MAGE-A family members are rarely found, being expressed only in testicular germ cells and placenta (Chomez et al., 2001) . Some members of this family are overexpressed in ovarian cancer cell lines that are resistant to paclitaxel and doxorubicin (Duan et al., 2003) . Interestingly, the APM cell line has already been described by us to be resistant to doxorubicin treatment (Labriola et al., 2009 ). Specifically, MAGE-A2 has already been shown to interact with p53 and repress its activity by recruiting transcription repressors [histone deacetylases (HDACs)] to p53 transcription sites, conferring resistance to chemotherapeutic agents (Monte et al., 2006) .
In addition to their participation in various neurodegenerative disorders and inflammatory diseases, 14-3-3 protein species, more abundant in the human insulinoma cell line, have been implicated in tumorigenesis either as potential tumor suppressors or oncogenes and have also been associated with poor survival of cancer patients (Kilani et al., 2007; Porter et al., 2006; Toyo-oka et al., 2003; Wilker and Yaffe, 2004 ). 14-3-3f in particular, is overexpressed in a number of lung cancer cell lines and in lung cancer patients tissues (Fan et al., 2007; Li et al., 2008; Qi et al., 2005; Zang et al., 2010) and has been implicated in their resistance to anoikis, a form of programmed cell death which is induced by anchorage-dependent cells detaching from the surrounding extracellular matrix, consequently promoting anchorage-independent growth (Li et al., 2008) . Intriguingly, as already described by our group, the APM cell line is able to form spheroids and proliferate under an anchorage-independent condition (Labriola et al., 2009 ).
Moreover, there are studies demonstrating that 14-3-3 proteins Subramanian et al., 2001) , and also specifically the f isoform (Subramanian et al., 2001; Yang et al., 2001) play important roles in preventing apoptosis through its binding to the pro-apoptotic protein BAD, integrating survival and apoptotic pathways (Porter et al., 2006) . Released BAD allows protein phosphatase 2A to dephosphorylate BAD's phosphoserine 112 (Chiang et al., 2003) , it then translocates from the cytoplasm to the mitochondria, where it can displace Bax from Bcl-xL (Zha et al., 1996) , leading to apoptosis. Interestingly, the growth-promoting activity of the Bad protein requires binding to the 14-3-3 protein (Maslyar et al., 2001) .
Of note is the recent report that dermcidin, found here as displaying higher levels in human insulinomas, inhibited glucose uptake in mice islets (Ghosh et al., 2011) . Furthermore, these authors demonstrated that the addition of aspirin, a known inhibitor of dermcidin action (Mukamal et al., 1999) , neutralized this effect on glucose uptake through the stimulation of NO synthesis. These results were not merely obtained in vitro, but the group also showed that oral administration of aspirin decreased plasma levels of dermcidin and restored insulin levels. Intriguingly, this protein had never been described in insulinoma cells, and in agreement with the very well characterized excessive and/or uncontrolled insulin release displayed by insulinomas and nesidioblastosis (Kaczirek et al., 2003; Wang et al., 2004) , the APM cell line does not present glucose-induced insulin secretion (Labriola et al., 2009) , which may, in part, be related to the increased levels of dermcidin in these cells.
The OTU domain-containing protein 7A (OTUD7A), a putative deubiquitinase (Kayagaki et al., 2007) , was found to be more abundant in the insulinoma cells. Nonetheless, little information about this protein is currently available.
Conclusions
All together, these results point at the potential value of the proteins uncovered here, since many of those identified in the APM cell line have never been previously described neither in human insulinomas nor in human islets, and they were all related to the observed cell phenotype. It is worth mentioning that the data obtained may also contribute to the still scarce knowledge on the molecular biology of insulinomas.
Finally, our study warrants further validation of some of these proteins in larger cohort samples as well as consideration for the development of insulinoma biomarkers and detection. Collectively, our observations prompt further research towards establishment of bioengineered human beta-cells as important models for experimental studies in transplantation and drug screening programs.
